Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

NUTRICHEM DIÄT + PHARMA GMBH - a B. Braun CompanyNUTRICHEM DIÄT + PHARMA GMBH - a B. Braun Company
VS
Teva PharmaceuticalsTeva Pharmaceuticals
NUTRICHEM DIÄT + PHARMA GMBH - a B. Braun Company

NUTRICHEM DIÄT + PHARMA GMBH - a B. Braun Company

Am Espan 1, Roth, 91154, DE

Last Update: 03/02/2026

View Profile
Between 750 and 799
http://www.nutrichem.de
752/1000Fair

NUTRICHEM DIÄT + PHARMA GMBH and its subsidiary inkospor® are part of the B. Braun Group of companies. NUTRICHEM DIÄT + PHARMA GMBH develops, manufactures, and packages high-quality nutritional and pharmaceutical products with state-of-the-art technology for clients ac...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:73
Subsidiaries:5
12-month incidents
0
Known data breaches
0
Attack type number
0
Teva Pharmaceuticals

Teva Pharmaceuticals

124 Dvora hanevi'a, Tel-Aviv, IL, 6944020

Last Update: 28/03/2026

View Profile
Between 800 and 849
http://www.tevapharm.com
805/1000Good

Teva Pharmaceuticals is a leading innovative biopharmaceutical company, enabled by a world-class generics business. For over 120 years, Teva’s commitment has never wavered. From innovating in the fields of neuroscience and immunology to providing complex generic medicin...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:29,951
Subsidiaries:5
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Ranges Comparison

Based On Specific Ai Models Category
NUTRICHEM DIÄT + PHARMA GMBH - a B. Braun Company

NUTRICHEM DIÄT + PHARMA GMBH - a B. Braun Company

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
Teva Pharmaceuticals

Teva Pharmaceuticals

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for NUTRICHEM DIÄT + PHARMA GMBH - a B. Braun Company in 2026.

Incidents

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Teva Pharmaceuticals in 2026.

Incidents

Incident History - NUTRICHEM DIÄT + PHARMA GMBH - a B. Braun Company (X = Date, Y = Severity)

NUTRICHEM DIÄT + PHARMA GMBH - a B. Braun Company cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - Teva Pharmaceuticals (X = Date, Y = Severity)

Teva Pharmaceuticals cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
NUTRICHEM DIÄT + PHARMA GMBH - a B. Braun Company

NUTRICHEM DIÄT + PHARMA GMBH - a B. Braun Company

Incidents
No explicit notable incidents reported.
Teva Pharmaceuticals

Teva Pharmaceuticals

Incidents
No explicit notable incidents reported.

FAQ

Between NUTRICHEM DIÄT + PHARMA GMBH - a B. Braun Company company and Teva Pharmaceuticals company, which one has the best AI Cybersecurity Score ?
Between NUTRICHEM DIÄT + PHARMA GMBH - a B. Braun Company company and Teva Pharmaceuticals company, which one has experienced more cyber incidents in the past ?
Between NUTRICHEM DIÄT + PHARMA GMBH - a B. Braun Company company and Teva Pharmaceuticals company, which one has experienced more cyber incidents this year ?
Between NUTRICHEM DIÄT + PHARMA GMBH - a B. Braun Company company and Teva Pharmaceuticals company, which one has experienced at least one ransomware attack ?
Between NUTRICHEM DIÄT + PHARMA GMBH - a B. Braun Company company and Teva Pharmaceuticals company, which one has experienced at least one data breach ?
Between NUTRICHEM DIÄT + PHARMA GMBH - a B. Braun Company company and Teva Pharmaceuticals company, which one has experienced at least one targeted cyberattack ?
Between NUTRICHEM DIÄT + PHARMA GMBH - a B. Braun Company company and Teva Pharmaceuticals company, which one has experienced at least one vulnerability ?
Between NUTRICHEM DIÄT + PHARMA GMBH - a B. Braun Company company and Teva Pharmaceuticals company, which one holds the most compliance certifications ?
Between NUTRICHEM DIÄT + PHARMA GMBH - a B. Braun Company company and Teva Pharmaceuticals company, which one holds the fewest compliance certifications ?
Between NUTRICHEM DIÄT + PHARMA GMBH - a B. Braun Company company and Teva Pharmaceuticals company, which one has the most subsidiaries ?
Between NUTRICHEM DIÄT + PHARMA GMBH - a B. Braun Company company and Teva Pharmaceuticals company, which one has the largest number of employees ?
Between NUTRICHEM DIÄT + PHARMA GMBH - a B. Braun Company and Teva Pharmaceuticals, which company holds both SOC 2 Type 1 certifications ?
Between NUTRICHEM DIÄT + PHARMA GMBH - a B. Braun Company and Teva Pharmaceuticals, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - NUTRICHEM DIÄT + PHARMA GMBH - a B. Braun Company or Teva Pharmaceuticals ?
Which company is PCI DSS compliant - NUTRICHEM DIÄT + PHARMA GMBH - a B. Braun Company or Teva Pharmaceuticals ?
Between NUTRICHEM DIÄT + PHARMA GMBH - a B. Braun Company and Teva Pharmaceuticals, which company complies with HIPAA regulations for healthcare data ?
Between NUTRICHEM DIÄT + PHARMA GMBH - a B. Braun Company and Teva Pharmaceuticals, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-71983
SUMMARY

MSI Radix AXE6600 router firmware version v781521 contains a command injection vulnerability in the wps.cgi interface that allows remote attackers to execute arbitrary commands by injecting malicious input through the pin2g, pin5g, or pin6g parameters. Attackers can exploit these unsanitized parameters to execute arbitrary commands on the affected device and obtain root privileges.

PUBLISHED
Date2026-08-08
UPDATED
Date2026-08-08
RISK INFORMATION (Score: 9.8)
CVSS3
Base Score: 9.8
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
CVSS4
Base Score: 9.3
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
5.9
EXPLOITABILITY
3.9
CVE-2026-71502
SUMMARY

CTI-Transmute contains a stored cross-site scripting vulnerability caused by insufficient neutralization of Vue template expression delimiters in server-rendered user-controlled data. An unauthenticated attacker can create a public conversion whose name or description contains a malicious Vue expression using the application's configured [[ ... ]] delimiters. User profile names may provide an additional injection vector. Although Jinja HTML escaping is applied, the resulting value is subsequently included in a DOM region compiled by Vue. Vue interprets the attacker-controlled value as a template expression rather than ordinary text. By accessing the JavaScript Function constructor from within the expression, an attacker can execute arbitrary JavaScript in the security context of the CTI-Transmute origin. The application's nonce-based Content Security Policy does not prevent exploitation because the Vue runtime compiler requires the unsafe-eval policy exception. The malicious payload is stored by the application and executed whenever another user opens an affected page, such as the public conversion detail page. The victim may be a normal user or an administrator. Successful exploitation could allow the attacker to: * Access data available to the victim through the application. * Extract API keys, tokens, or other sensitive information exposed to the page. * Perform authenticated actions using the victim's session. * Modify conversions or other application data. * Escalate the impact by targeting an administrator. A demonstrated payload can use [].constructor.constructor(...) to obtain the JavaScript Function constructor and execute arbitrary code. The regression tests also show that a short first-stage payload could retrieve an uncapped conversion description and evaluate a larger second-stage payload. The patch addresses the vulnerability by registering a global Jinja finalize hook that inserts a zero-width Unicode word joiner inside every Vue delimiter found in server-rendered values. This prevents Vue from recognizing the values as template expressions while preserving their visible representation.

PUBLISHED
Date2026-08-08
UPDATED
Date2026-08-08
RISK INFORMATION (Score: )
CVSS4
Base Score: 5.1
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:A/VC:L/VI:L/VA:N/SC:L/SI:L/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
NA
EXPLOITABILITY
NA
CVE-2026-71958
SUMMARY

D-Link DWR-M961 devices with hardware version C1 and software version 1.1.2_C1_202602110044 contain a buffer overflow vulnerability in the quicksetup.cgi interface. A remote attacker can write overly long strings to the test4, ssid2, and username fields and execute arbitrary commands by crafting a specific payload, or cause the device to crash.

PUBLISHED
Date2026-08-08
UPDATED
Date2026-08-08
RISK INFORMATION (Score: 9.8)
CVSS3
Base Score: 9.8
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
CVSS4
Base Score: 9.3
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
5.9
EXPLOITABILITY
3.9
CVE-2026-71957
SUMMARY

D-Link DWR-M961 devices with hardware version C1 and software version 1.1.2_C1_202602110044 contain a buffer overflow vulnerability in the app.cgi interface. A remote attacker can write an overly long string to the netAcc.addlist[].name field and execute arbitrary commands by crafting a specific payload, or cause the device to crash.

PUBLISHED
Date2026-08-08
UPDATED
Date2026-08-08
RISK INFORMATION (Score: 9.8)
CVSS3
Base Score: 9.8
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
CVSS4
Base Score: 9.3
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
5.9
EXPLOITABILITY
3.9
CVE-2026-71956
SUMMARY

D-Link DWR-M961 devices with hardware version C1 and software version 1.1.2_C1_202602110044 contain a command injection vulnerability in the app.cgi interface. A remote attacker can inject arbitrary malicious commands into the netDig.ping.dst field, resulting in command execution with root privileges.

PUBLISHED
Date2026-08-08
UPDATED
Date2026-08-08
RISK INFORMATION (Score: 9.8)
CVSS3
Base Score: 9.8
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
CVSS4
Base Score: 9.3
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
5.9
EXPLOITABILITY
3.9